Immunogenicity, Safety and Protective Effect of Live Attenuated Varicella Vaccine and Study on Antibody Level and Etiology of Varicella Zoster Virus
Clinical trial NCT05460429 · UNKNOWN
Trial details
- NCT number
- NCT05460429
- Sponsor
- Sinovac (Dalian) Vaccine Technology Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-30
- Primary completion
- 2023-03-15
- Enrollment
- 37920
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.